CME vs. CLS.TO
CME (CME Group Inc.) and CLS.TO (Celestica Inc.) are both stocks. CME operates in Financial Data & Stock Exchanges (Financial Services), while CLS.TO operates in Electronic Components (Technology). Over the past 10 years, CME returned 15.38%/yr vs 43.71%/yr for CLS.TO. At a 0.18 correlation, their price movements are largely independent.
Performance
CME vs. CLS.TO - Performance Comparison
Loading charts...
Different Trading Currencies
CME is traded in USD, while CLS.TO is traded in CAD. To make them comparable, the CLS.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CME achieves a 1.58% return, which is significantly lower than CLS.TO's 32.76% return. Over the past 10 years, CME has underperformed CLS.TO with an annualized return of 15.38%, while CLS.TO has yielded a comparatively higher 43.71% annualized return.
CME
- 1D
- 2.80%
- 1M
- -8.82%
- YTD
- 1.58%
- 6M
- 1.41%
- 1Y
- 3.34%
- 3Y*
- 19.92%
- 5Y*
- 9.17%
- 10Y*
- 15.38%
CLS.TO
- 1D
- 1.99%
- 1M
- 5.68%
- YTD
- 32.76%
- 6M
- 28.56%
- 1Y
- 202.30%
- 3Y*
- 207.61%
- 5Y*
- 116.14%
- 10Y*
- 43.71%
CME vs. CLS.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CME CME Group Inc. | 1.58% | 19.83% | 15.41% | 31.32% | -22.89% | 29.47% | -6.34% | 9.67% | 32.15% | 32.35% |
CLS.TO Celestica Inc. | 32.69% | 220.69% | 215.14% | 160.52% | 1.78% | 37.36% | -2.32% | -6.08% | -16.29% | -11.14% |
Correlation
The correlation between CME and CLS.TO is -0.18, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.00 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2006 | 0.18 |
The correlation between CME and CLS.TO shifts across timeframes, from -0.18 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CME:
$97.90B
CLS.TO:
CA$63.66B
CME:
$11.75
CLS.TO:
$8.28
CME:
22.94
CLS.TO:
47.51
CME:
2.00
CLS.TO:
0.64
CME:
14.40
CLS.TO:
3.30
CME:
3.68
CLS.TO:
21.70
CME:
$6.76B
CLS.TO:
$13.81B
CME:
$5.84B
CLS.TO:
$1.60B
CME:
$5.69B
CLS.TO:
$1.36B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CME vs. CLS.TO — Risk / Return Rank
CME
CLS.TO
CME vs. CLS.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CME Group Inc. (CME) and Celestica Inc. (CLS.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CME | CLS.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.67 | ||
| Sortino ratioReturn per unit of downside risk | -2.48 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.38 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | 6.89 | -6.73 |
| Martin ratioReturn relative to average drawdown | 0.50 | 17.06 | -16.56 |
Loading charts...
Drawdowns
CME vs. CLS.TO - Drawdown Comparison
The maximum CME drawdown since its inception was -77.50%, roughly equal to the maximum CLS.TO drawdown of -80.63%. Use the drawdown chart below to compare losses from any high point for CME and CLS.TO.
Loading charts...
Drawdown Indicators
| CME | CLS.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.50% | -80.63% | +3.13% |
Max Drawdown (1Y)Largest decline over 1 year | -21.42% | -29.56% | +8.14% |
Max Drawdown (3Y)Largest decline over 3 years | -21.42% | -53.42% | +32.00% |
Max Drawdown (5Y)Largest decline over 5 years | -31.74% | -53.42% | +21.68% |
Max Drawdown (10Y)Largest decline over 10 years | -37.36% | -80.63% | +43.27% |
Current DrawdownCurrent decline from peak | -15.03% | -16.56% | +1.53% |
Average DrawdownAverage peak-to-trough decline | -20.68% | -26.16% | +5.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.70% | 11.91% | -5.21% |
Volatility
CME vs. CLS.TO - Volatility Comparison
The current volatility for CME Group Inc. (CME) is 10.45%, while Celestica Inc. (CLS.TO) has a volatility of 28.03%. This indicates that CME experiences smaller price fluctuations and is considered to be less risky than CLS.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CME | CLS.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.45% | 28.03% | -17.58% |
Volatility (6M)Calculated over the trailing 6-month period | 17.44% | 55.40% | -37.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.74% | 72.00% | -51.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.15% | 56.84% | -36.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.93% | 49.39% | -25.46% |
Dividends
CME vs. CLS.TO - Dividend Comparison
CME's dividend yield for the trailing twelve months is around 4.17%, while CLS.TO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLS.TO Celestica Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CME CME Group Inc. | 4.17% | 1.83% | 4.48% | 4.58% | 5.05% | 3.00% | 3.24% | 2.74% | 2.42% | 4.20% | 4.90% | 5.41% |
Financials
CME vs. CLS.TO - Financials Comparison
This section allows you to compare key financial metrics between CME Group Inc. and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CME vs. CLS.TO - Profitability Comparison
CME - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a gross profit of 1.66B and revenue of 1.88B. Therefore, the gross margin over that period was 88.1%.
CLS.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a gross profit of 437.20M and revenue of 4.05B. Therefore, the gross margin over that period was 10.8%.
CME - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported an operating income of 1.31B and revenue of 1.88B, resulting in an operating margin of 69.7%.
CLS.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported an operating income of 267.70M and revenue of 4.05B, resulting in an operating margin of 6.6%.
CME - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CME Group Inc. reported a net income of 1.15B and revenue of 1.88B, resulting in a net margin of 61.4%.
CLS.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Celestica Inc. reported a net income of 212.30M and revenue of 4.05B, resulting in a net margin of 5.3%.
Frequently Asked Questions
CME and CLS.TO have a correlation of -0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CME and CLS.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer